Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Analysts are expecting strong growth driven by the robust sales of Lilly's https://chiaraakup017220.pointblog.net/eli-lilly-s-q3-performance-an-in-depth-look-84748839